Peter Artymiuk

This inventor holds 9 USPTO granted patents and 12 published patent applications and 3 EPO patents. Top assignee: Asterion, Inc.. Active years: 2008-2018.

USPTO Granted Patents = 9 (Patent Applications = 12)

% Patents Active = 11.1

EPO Patents = 3 (Patent Applications = 15)

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 19(Granted Patents)

Company Filing History:

9 out of 14

Asterion, Inc.

patents

Years Active: 2008-2018

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10030062 - Growth hormone fusion proteins with growth hormone receptor agonist activity (2018-07-24),

2. 9493536 - Growth hormone receptor antagonists (2016-11-15),

3. 8470559 - Growth hormone fusion proteins (2013-06-25),

4. 8293709 - Growth hormone fusion proteins (2012-10-23),

5. 8273552 - Modified growth hormone polypeptides (2012-09-25),

6. 8173782 - Fusion protein comprising growth hormone and growth hormone receptor (2012-05-08),

7. 7625998 - Cytokine polypeptides and antibodies containing a signal sequence for the attachment of glycosylphosphatidylinositol (2009-12-01),

8. 7524649 - Modified growth hormone fusion polypeptides (2009-04-28),

9. 7446183 - Fusion protein comprising growth hormone and growth hormone receptor (2008-11-04),

Title: Innovations of Peter Artymiuk in Growth Hormone Research

Introduction

Peter Artymiuk is a notable inventor based in Sheffield, GB. He has made significant contributions to the field of biotechnology, particularly in the development of growth hormone-related therapies. With a total of 9 patents to his name, Artymiuk's work has the potential to impact the treatment of various growth hormone-related diseases.

Latest Patents

Among his latest patents, Artymiuk has developed growth hormone fusion proteins with growth hormone receptor agonist activity. These proteins exhibit increased in vivo stability and activity, which is crucial for effective treatment. Additionally, he has patented growth hormone receptor antagonists, which also demonstrate enhanced stability and activity. These innovations include nucleic acid molecules encoding the proteins and methods for treating diseases that could benefit from growth hormone agonists or antagonists.

Career Highlights

Artymiuk's career is marked by his dedication to advancing medical science through innovative research. His work at Asterion, Inc. has positioned him as a key player in the biotechnology sector. His inventions are paving the way for new therapeutic options for patients suffering from growth hormone deficiencies and related conditions.

Collaborations

Peter Artymiuk has collaborated with esteemed colleagues such as Richard Ross and Jon Sayers. These partnerships have fostered a collaborative environment that enhances the research and development of groundbreaking therapies.

Conclusion

In summary, Peter Artymiuk's contributions to growth hormone research through his patents and collaborations highlight his role as an influential inventor in the biotechnology field. His work continues to inspire advancements in medical treatments that can improve patient outcomes.